Synthesis and calcium channel antagonist activities of 3-nitrooxyalkyl, 5-alkyl 1,4-dihydro-2,6-dimethyl-4-(1-methyl-5-nitro-2-imidazolyl)-3,5-pyridinedicarboxylates
A group of racemic 3-[(2-nitrooxyethyl), (3-nitrooxypropyl), (4-nitrooxybutyl) or (1,3-dinitrooxy-2-propyl)], 5-methyl (ethyl or propyl) 1,4-dihydro-2,6-dimethyl-4-(1-methyl-5-nitro-2-imidazolyl)-3,5-pyridinedicarboxylates ( 18– 29) were synthesized using modified Hantzsch reaction that involved the...
Saved in:
Published in: | Farmaco (Società chimica italiana : 1989) Vol. 57; no. 2; pp. 123 - 128 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
France
Elsevier SAS
01-02-2002
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A group of racemic 3-[(2-nitrooxyethyl), (3-nitrooxypropyl), (4-nitrooxybutyl) or (1,3-dinitrooxy-2-propyl)], 5-methyl (ethyl or propyl) 1,4-dihydro-2,6-dimethyl-4-(1-methyl-5-nitro-2-imidazolyl)-3,5-pyridinedicarboxylates (
18–
29) were synthesized using modified Hantzsch reaction that involved the condensation of 2-nitrooxyethyl (
8), 3-nitrooxypropyl (
9), 4-nitrooxybutyl (
10) or 1,3-dinitrooxy-2-propyl (
13) acetoacetate with methyl (
14), ethyl (
15) or isopropyl (
16) 3-aminocrotonate and 1-methyl-5-nitroimidazole-2-carboxaldehyde (
17). In vitro calcium channel antagonist activities were determined using a guinea pig ileum longitudinal smooth muscle assay. Compounds
18–
29 exhibited superior, or equipotent, calcium antagonist activity (IC
50=10
−11–10
−13 M range) relative to the reference drug nifedipine (IC
50=1.07±0.12×10
−11 M), which could serve as potential probes to investigate the in vivo release of nitric oxide which induces vascular muscle relaxation. |
---|---|
ISSN: | 0014-827X 1879-0569 |
DOI: | 10.1016/S0014-827X(01)01183-1 |